Analgesics: synthesis of 1-dioxolanoalkylnormeperidines and 1-dioxanoalkylnormeperidines.

DOI: 10.1002/jps.2600600833

Source and publish data:

Journal of Pharmaceutical Sciences p. 1250 - 1251 (1971)

Update date:2022-08-02

Topics:

Authors:

Kriesel Kriesel

Gisvold Gisvold

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1002/jps.2600600833

Full text of DOI:10.1002/jps.2600600833

Products guided by the article

Product name:1-(2-[1,3]dioxan-2-yl-ethyl)-4-phenyl-piperidine-4-carboxylic acid ethyl ester

Cas No:47419-68-1

R&D Labs maybe for 47419-68-1

Yueyang Hudex Pharmaceuticals Ltd.

Contact:0730-8748800

Address:Wujiang Bridge，Yueyang Economy & Technology Development Zone
Taizhou Elitechemie MediPharma Technology Co.,Ltd.

Contact:+86-523-86810021

Address:Building G14,NO.1 Avenue,China Medical City, Taizhou, Jiangsu,China
Shanghai Mintchem Development ., Ltd

Contact:0086 21 5190 8570

Address:R602,4#,89Nong, Mudan Road Pudong Shanghai China
Chemsigma International Co.,Ltd.

website:http://www.chemsigma.com

Contact:86-025-58748998

Address:Rm.705, 15th Building,Rd.Xinke II
Huayang chemical Co., LTD

Contact:+86-18653358619

Address:zibo

Relevant to this article

The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-α) production

Doi:10.1016/j.bmcl.2005.02.066
(2005)
An Approach to Serrulatane Diterpenes via endo-Selective Conjugate Nucleophilic Addition to Arene-Cr(CO)₃ Complexes

Doi:10.1021/ol026827a
(2002)
(S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]-3-phenylacrylamide: An orally bioavailable KCNQ2 opener with significant activity in a cortical spreading depression model of migraine

Doi:10.1021/jm034073f
(2003)
Doi:10.1007/BF02541338
(1968)
Doi:10.1021/ja01238a042
()
Cell-Based Selection Expands the Utility of DNA-Encoded Small-Molecule Library Technology to Cell Surface Drug Targets: Identification of Novel Antagonists of the NK3 Tachykinin Receptor

Doi:10.1021/acscombsci.5b00124
(2015)

Article Doi